Cargando…
Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study
BACKGROUND: Mild cognitive impairment in Parkinson’s disease (PD-MCI) is associated with an increased risk of cognitive decline. PD-MCI is characterized by impairments in executive function and visuospatial recognition. The visuospatial n-back test is useful for assessing both domains. The 0-back te...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103297/ https://www.ncbi.nlm.nih.gov/pubmed/35562711 http://dx.doi.org/10.1186/s12883-022-02699-x |